Thermo Fisher Join W...
Thermo Fisher's ...
3rd March 2020 Editorial by: Thermo Fisher Scientific (Clinical Applications)
Thermo Fisher Acquire Qiagen
Thermo Fisher Scientific Inc. and QIAGEN N.V. announced that their boards of directors, as well as the managing board of QIAGEN N.V., have unanimously approved Thermo Fisher's proposal to acquire QIAGEN for €39 per share in cash. The offer price represents a premium of approximately 23% to the closing price of QIAGEN's common stock on the Frankfurt Prime Standard on March 2, 2020, the last trading day prior to the announcement of the transaction. Thermo Fisher will commence a tender offer to acquire all of the ordinary shares of QIAGEN.
The transaction values QIAGEN at approximately $11.5 billion at current exchange rates, which includes the assumption of approximately $1.4 billion of net debt.
Tags:
Date Published: 3rd March 2020
Source article link: View
Thermo Fisher Join With Cedars-Sinai
Thermo Fisher's Taqman COVID-19
Thermo Fisher Scientific (Clinical Applications)
Address:
Basingstoke
United Kingdom
Tel: +44 (0)7825093757
Related news from Thermo Fisher Scientific (Clinical Applications)
- Superbug Surcharge: The Economics of MDROs and HAIs
- How AST Results Support Accurate Antibiotic Therapy in the Battle Against Bacterial Sepsis
- New Sample Preparation Solutions to Simplify and Automate Respiratory Diagnostic Testing
- Research Panel Detects Four of the Most Common STI Pathogens With One Panel
- FDA EUA for TaqPath Monkeypox/Orthopox Virus DNA Kit
- Fast Forward to Actionable Results With Rapid AST
- New Non-Hazardous Viral Inactivation Medium Supports Safe Collection and Transport of SARS-CoV-2
- MIC Results in 6 Hours with New Rapid AST System
- Seasonal Flu and Coronavirus Identification
- Flu Testing During COVID-19
- Thermo Fisher's US Contract Will See 8 Million COVID-19 VTM-Filled Tubes Per Week
- Thermo Fisher's Taqman COVID-19 Diagnostic Kit Receives FDA Emergency Use Authorization
- Thermo Fisher Join With Cedars-Sinai to Develop Advanced Analytical Workflows for Clinical Labs
- Thermo Fisher Focus on Microbiology at AACC
- New Microbroth Dilution Plates Provide Gold Standard-level MIC Accuracy for MDROs
- New Sensititre™ARIS HiQ™ AST System Automates Gold Standard MIC by Broth Microdilution
- World's First Smart qPCR Instruments
- Delafloxacin and Meropenem/Vaborbactam Now Available on Sensititre ID/AST System
- FDA-cleared Microbroth Dilution Plates for Delafloxacin and Meropenem/Vaborbactam
- New Bovine/Porcine-specific Standard Sensititre Plate